A University of Oklahoma researcher is developing a novel therapy for Alzheimer's disease using "biopharmaceutical proteases" to attack the toxic plaque that builds up in the brain of an Alzheimer's patient.
This is an approach that he predicts will be lower in cost and higher in effectiveness than current therapies.